XORTX Therapeutics (XRTX) Receivables - Net (2020 - 2026)
XORTX Therapeutics (XRTX) posted Receivables - Net of $64633.0 for Q1 2026, down 19.38% on a QoQ basis from $80172.0 in Q4 2025, and up 274.64% year-over-year from $17252.0 in Q1 2025.
XORTX Therapeutics (XRTX) Receivables - Net (2020 - 2026) Analysis & Trends
XORTX Therapeutics' Receivables - Net history runs 7 years deep, the most recent figure standing at $64633.0 for Q1 2026.
- Quarterly Receivables - Net rose 274.64% year-over-year to $64633.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $64633.0 (up 274.64% YoY) and the FY2025 annual result came in at $80172.0, up 354.57% from the prior year.
- Receivables - Net was $64633.0 for Q1 2026 at XORTX Therapeutics, down from $80172.0 in the prior quarter.
- Across five years, Receivables - Net topped out at $195583.2 in Q2 2022 and bottomed at $10860.0 in Q2 2025.
- A 5-year average of $55395.9 and a median of $36421.0 in 2023 frame the typical range for Receivables - Net.
- Annual changes were most pronounced in 2023 — Receivables - Net sank 84.45% — and 2025, when it surged 354.57%.
- XORTX Therapeutics' Receivables - Net stood at $81575.1 in 2022, then slipped by 25.58% to $60711.0 in 2023, then slumped by 70.95% to $17637.0 in 2024, then soared by 354.57% to $80172.0 in 2025, then slipped by 19.38% to $64633.0 in 2026.
- Business Quant data shows XRTX's Receivables - Net at $64633.0 in Q1 2026, $80172.0 in Q4 2025, and $22092.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,801.52 Bn | 66,801.23 Bn | - |
| 2 | Nanobiotix | 1,916.61 Bn | 1,916.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.65 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.69 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.09 Bn | 3.31 Bn |
| 7 | Belite Bio | 63.06 Bn | 63.06 Bn | - |
| 8 | Argenx Se | 55.74 Bn | 50.56 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.48 Bn | 37.48 Bn | - |
| 10 | XORTX Therapeutics | 2.91 Bn | 2.91 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 64,633.00 |
| Mar 31, 2026 | 64,633.00 |
| Dec 31, 2025 | 80,172.00 |
| Dec 31, 2025 | 80,172.00 |
| Sep 30, 2025 | 22,092.00 |
| Sep 30, 2025 | 22,092.00 |
| Jun 30, 2025 | 10,860.00 |
| Jun 30, 2025 | 10,860.00 |
| Mar 31, 2025 | 17,252.00 |
| Mar 31, 2025 | 17,252.00 |
| Dec 31, 2024 | 17,637.00 |
| Dec 31, 2024 | 17,637.00 |
| Sep 30, 2024 | 13,111.00 |
| Sep 30, 2024 | 13,111.00 |
| Jun 30, 2024 | 22,807.00 |
| Jun 30, 2024 | 22,807.00 |
| Mar 31, 2024 | 30,883.00 |
| Mar 31, 2024 | 30,883.00 |
| Dec 31, 2023 | 60,711.00 |
| Dec 31, 2023 | 60,711.00 |